NSEGranting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals2d ago · 23 Sept 2026, 04:10 pm

Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

IOL Chemicals and Pharmaceuticals Limited · IOLCP

✦ AI Summary▲ PositiveRegulatory

IOL Chemicals and Pharmaceuticals Limited has received REACH certification/registration for its product 'Triacetin' under the EU-REACH framework, enabling the company to export the product across European Union countries.

Analysis Scores

Earnings Impact2/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about EU-REACH Registration for Triacetin

Attachments (1)

📄

IOLCP_23092026161029_Intimation230926.pdf

pdf

Download →
View document text
23rd September 2026 IOLCP/CGC/2026 National Stock Exchange of India Ltd BSE Limited Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (E) Dalal Street Mumbai - 400 051 Mumbai – 400 001 Security Symbol: IOLCP Security Code: 524164 Subject: EU-REACH Registration for Triacetin Dear Sirs, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January 2026, we are pleased to inform that the Company has received REACH certification /registration for its product “Triacetin” under the applicable EU- REACH framework. This certification enables the Company to export Triacetin across all the countries in European Union. This registration further strengthens the Company’s regulatory compliance and market access in international markets and supports its continued focus on expanding its presence in global markets through product registrations and regulatory approvals. Details required under abovesaid SEBI Master Circular is annexed herewith as “Annexure -1”. This information will also be accessible on the Company’s website: www.iolcp.com. You are requested to take the above information on record. Thanking You, Yours faithfully, for IOL Chemicals and Pharmaceuticals Limited Abhay Raj Singh Sr. Vice President & Company Secretary Annexure -1 Details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026, is annexed herewith Particulars Details European Chemicals Agency (ECHA) under the EU REACH a) Name of the regulatory or (Registration, Evaluation, Authorisation and Restriction of licensing authority Chemicals) framework. The Company has received REACH certification /registration b) Brief details of the for its product “Triacetin” under the applicable EU-REACH approval/license obtained framework. The registration enables the Company to Export its product c) Impact/relevance of such "Triacetin" in European markets. The registration further approval/license to the listed supports the Company’s regulatory compliance and access to entity the European market. d) Withdrawal/cancellation or Not Applicable. suspension The registration is valid in accordance with the applicable e) Period for which such provisions of the EU REACH Regulation and is subject to approval/license is/was valid continued compliance with the applicable regulatory requirements. f) Subsequent actual Not Applicable, impact/corrective actions